title: Prime-boost immunization strategies against HIV.
authors.affiliation: Chiron Corporation, Emeryville, California 94608, USA.
authors.forename: S W
authors.initials: SW
authors.lastname: Barnett
authors.forename: J M
authors.initials: JM
authors.lastname: Klinger
authors.forename: B
authors.initials: B
authors.lastname: Doe
authors.forename: C M
authors.initials: CM
authors.lastname: Walker
authors.forename: L
authors.initials: L
authors.lastname: Hansen
authors.forename: A M
authors.initials: AM
authors.lastname: Duliège
authors.forename: F M
authors.initials: FM
authors.lastname: Sinangil
mesh_terms: D016915:AIDS Vaccines / Q000276:immunology*; D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic; D015483:HIV Antibodies / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D019302:HIV Envelope Protein gp160 / Q000276:immunology; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D009500:Neutralization Tests; D002679:Pan troglodytes; D014614:Vaccines, Synthetic / Q000276:immunology
chemical_list: D016915:AIDS Vaccines; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D019302:HIV Envelope Protein gp160; D014614:Vaccines, Synthetic